Study on the Correlation Between the Expression of NF-Ƙb in the Alveolar Lavage Fluid of Children with Severe Mycoplasma Pneumoniae Pneumonia, Its Clinical Characteristics, and Cellular Immunity
Xinyao Ding,Shujun Li,Xue Liu,Xiaowen Zhan,Zhiyuan Wang,Mengzhu Wang,Guannan Wu
DOI: https://doi.org/10.2147/idr.s411361
2024-06-20
Infection and Drug Resistance
Abstract:Xinyao Ding, 1 Shujun Li, 2 Xue Liu, 2 Xiaowen Zhan, 2 Zhiyuan Wang, 2 Mengzhu Wang, 2 Guannan Wu 3 1 Department of Paediatrics, Luohe Yancheng District People's Hospital, Luohe, Henan, 462300, People's Republic of China; 2 Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan, 453100, People's Republic of China; 3 Department of ICU, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan, 453100, People's Republic of China Correspondence: Shujun Li, Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, No. 88 of Jiankang road, Weihui, Henan, 453100, People's Republic of China, Tel +8613781905766, Email Objective: This study explored the level of nuclear factor-ƙB (NF-ƙB) in the bronchoalveolar lavage fluid (BALF) of children with severe Mycoplasma Pneumoniae pneumonia (SMPP) and the correlation between NF-ƙB, cellular immunity, and clinical characteristics. Methods: A total of 41 hospitalized children diagnosed with SMPP were selected and included in the SMPP group, and 13 bronchial foreign bodies (FB) without infection during the same period were included in the FB group. The NF-ƙB in the BALF of participants was detected by enzyme-linked immunosorbent assay. The correlation between NF-ƙB and laboratory findings, cellular immunity, and the clinical features in children with SMPP was analyzed. The differences in chest imaging and bronchoscopy in children with SMPP were observed. Results: The levels of NF-ƙB were significantly increased in the SMPP group compared with the FB group (P < 0.001). There were correlations between different NF-ƙB pairs in the SMPP group (P < 0.01). Nuclear factor-ƙB (NF-ƙB) correlated with IL-6, the mycoplasma load in BALF, fever peak, length of hospital stay, and sputum suppository (P < 0.05). The higher the intracellular NF-ƙB level in BALF, the lower the CD3+ CD4+ value in peripheral blood (P < 0.05). Intracellular NF-ƙB and total NF-ƙB correlated with pleural effusion, pericardial effusion, and extrapulmonary complications (P < 0.05). Conclusion: NF-ƙB is involved in airway inflammation changes in children with SMPP. The higher the level of NF-ƙB in the airway, the more severe the clinical manifestations, and the longer the length of hospital stay is likely to be. Keywords: mycoplasma pneumoniae pneumonia, bronchoalveolar lavage fluid, NF-ƙB, cellular immunity, children Community acquired pneumonia (CAP) is one of the leading causes of pediatric disease and child mortality worldwide, 1 with 10% to 40% of CAP caused by Mycoplasma pneumoniae pneumonia (MPP) and about 18% requiring hospitalization; approximately 12% of hospitalized children with MPP infection need to be transferred to the intensive-care unit for further treatment. 2 The incidence of severe MPP (SMPP) has been on the rise worldwide in the past five years. 3 SMPP can cause severe lung injury, accompanied by multiple organ injury outside the lung and can be combined with multiple organ dysfunction and serious long-term sequelae, affect the prognosis and quality of life of children with SMPP, increase the burden on their families, and may even be life-threatening. 4 Therefore, the diagnosis and treatment of SMPP in children pose a great challenge to pediatricians. Within a broader scope, it also draws the attention of pediatricians in terms of how to recognize MPP early, diagnose and treat the condition in time to prevent it from developing into SMPP, and avoid complications and sequelae. Mycoplasma Pneumoniae (MP) is detected mainly by isolation and culture, serological specificity and non-specificity experiments, nucleic acid amplification technology, and other pathogenic techniques. 5 Treatment of MPP involves the administration of antibiotics, steroids, or intravenous immunoglobulins that disrupt protein synthesis (eg, macrolides and tetracyclines) and inhibit DNA replication (such as fluoroquinolones), 6 as well as prompt bronchoscopy and bronchoalveolar lavage treatment. At present, the pathogenesis of MPP is unclear. Virulence factors of Mycoplasma pneumoniae and pathogen-mediated pathogenesis may be related to adhesion to the surface of host cells, direct cytotoxicity to host cells, immune damage induced by an inflammatory response, and immune escape. 7 Mycoplasma pneumoniae encodes a variety of virulence factors, including membrane polysaccharides, glycolipids, cohesins, community-acquired respiratory distress syndrome toxins and toxic metabolites. 8 Serum IgE levels were significantly elevated in children with MP-associated extr -Abstract Truncated-
pharmacology & pharmacy,infectious diseases